Non categorizzato Novartis’ EPS down 40% to $0.77 in Q2 Luglio 19, 2022 0 commenti Novartis announced on Tuesday that its net sales in the second quarter of 2022 stood at $12.8 billion, falling 1% from the same period a year ago. Earnings per share (EPS) plunged 40% year on year to … About the author:
Get involved!
Comments